Prognostic value of the systemic inflammation response index (SIRI) in glioma: A meta-analysis
PLOS One · 02.11.2026 · 21 (11) · e0362113
DOI: 10.1371/journal.pone.0362113 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS One, online erschienen am 02.11.2026. Verfasst von Lixia Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical College, Xizang University, LhasaTibet, China. Hauptthemen laut MEDLINE: Glioma, Inflammation, Brain Neoplasms. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the project of Regional Collaborative Innovation Special Program of Lhasa, Science and technology project of Tibet Autonomous Region, Key science and technology project of Lhasa.
Abstract (Originalsprache)
Objective
To systematically evaluate the predictive value of systemic inflammation response index (SIRI) for the prognosis of glioma patients.
Methods
PubMed, Cochrane Library, EMBASE, and Web of Science databases were searched to collect literature on the relationship between SIRI and glioma prognosis from database inception to July 2026. The primary outcome measures were overall survival (OS) and progression-free survival (PFS). STATA 15.0 and Review Manager 5.4 software were used, and random-effects models were employed with pooled hazard ratios (HR) and their 95% confidence intervals (CI) to assess the prognostic value of SIRI. Subgroup analyses, sensitivity analyses, and publication bias assessments were performed.
Results
Eight retrospective cohort studies involving 1778 glioma patients were included, forming 12 comparison groups for OS analysis and 4 comparison groups for PFS analysis. Meta-analysis results showed that a higher SIRI was significantly associated with poorer OS (pooled HR = 1.79, 95% CI: 1.34–2.38, P < 0.0001) and PFS (pooled HR = 1.46, 95% CI: 1.18–1.81, P = 0.0005) in glioma patients. Subgroup analysis showed that the prognostic value of SIRI for OS was not significant in the European population subgroup, suggesting that the association may be modulated by geographic region. Sensitivity analysis confirmed the robustness of the results. Egger’s test indicated publication bias in the OS analysis (P = 0.0001), but no significant bias was found in the PFS analysis.
Conclusion
This meta-analysis suggests that elevated SIRI is associated with poorer OS and PFS in glioma patients, although this association was not consistently observed across all subgroups, particularly in European populations. These findings highlight the need for further validation with standardized cut-off values in diverse populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical College, Xizang University, LhasaTibet, China.
- Department of Neurosurgery, People's Hospital of Xizang Autonomous Region, Lhasa, Xizang Autonomous Region, China.
ORCID-Profile: Huandong Liu
Förderung
- the project of Regional Collaborative Innovation Special Program of Lhasa
- Science and technology project of Tibet Autonomous Region
- Key science and technology project of Lhasa
Zitieren
APA
Guo, L., Cao, X., Yang, L., Zhu, X., Liu, L., & Liu, H. (2026). Prognostic value of the systemic inflammation response index (SIRI) in glioma: A meta-analysis. PLOS One, 21(11), e0362113. https://doi.org/10.1371/journal.pone.0362113
Vancouver
Guo L, Cao X, Yang L, Zhu X, Liu L, Liu H. Prognostic value of the systemic inflammation response index (SIRI) in glioma: A meta-analysis. PLOS One. 2026;21(11):e0362113. doi:10.1371/journal.pone.0362113
BibTeX
@article{Guo2026,
author = {Guo, Lixia and Cao, Xudong and Yang, Lijun and Zhu, Xiaoyan and Liu, Lan and Liu, Huandong},
title = {Prognostic value of the systemic inflammation response index (SIRI) in glioma: A meta-analysis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0362113},
doi = {10.1371/journal.pone.0362113}
}
EUVIMED